CFO exercised or converted 1,078 BIO derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Apr 24, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Apr 28, 2026
CFOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001396867-26-000002
Filed / recordedApr 28, 2026, 4:21 PM UTCAdded to OQROOct 6, 2026, 4:40 PM UTC Data qualityVerified: identifiers matched exactly IssuerBIO-RAD LABORATORIES, INC. Reporting personRoop Kalyan Lakkaraju Officer titleEVP, Chief Financial Officer SecurityBio-Rad A Common Stock TableNon-derivative (Table I) Transaction dateApr 24, 2026 Acquired / disposedAcquired (A) Shares owned after2,983.895 Footnotes from the filing
- Shares of Class A common stock acquired on the vesting of restricted stock units.
- Includes 62.2360 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2026.
Around the same time
Bio-Rad Laboratories's President, CDG sold $136K of Bio-Rad Laboratories shares. Nobody planned it ahead of time.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.